Skip to content

Clinical efficacy study of Shengmai San combined with Yangxin Tang in the treatment of ventricular premature beats of qi and yin deficiency type

Clinical efficacy study of Shengmai San combined with Yangxin Tang in the treatment of ventricular premature beats of qi and yin deficiency type

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000800
Enrollment
Unknown
Registered
2025-04-22
Start date
2025-04-18
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventricular premature beats

Interventions

control group:Basic treatment
Treatment group:Basic treatment+Shengmai San combined with Yangxin Tang

Sponsors

Yueyang Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Age = 18 years old and = 75 years old gender not limited; (2) Meets the diagnostic criteria for palpitations and qi yin deficiency in traditional Chinese medicine; (3) Meets the diagnostic criteria for ventricular premature beats in Western medicine with a Lown classification of II = ventricular and IVa = IVa; (4) Patients with persistent clinical symptoms (>30 minutes/day) and no improvement in lifestyle despite improvement; (5) Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Individuals with organic heart disease such as acute coronary syndrome dilated cardiomyopathy hypertrophic cardiomyopathy and hypertension grade 3 or above; (2) Individuals with a heart rate of less than 60 beats per minute and severe bradycardia such as sick sinus syndrome ventricular or atrioventricular block or other rapid arrhythmias; (3) Patients with severe primary diseases such as cerebrovascular liver kidney endocrine or hematopoietic systems or various infectious diseases; (4) Those who have taken other antiarrhythmic drugs traditional Chinese medicine and traditional Chinese patent medicines and simple preparations in recent 4 weeks; (5) Individuals with mental disorders or those who are unable to understand or cooperate with the investigation; (6) Allergic constitution known or possibly allergic to the test drug or its components; (7) Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
The therapeutic effect of 24-hour dynamic electrocardiogram on ventricular premature beats frequency;

Secondary

MeasureTime frame
Traditional Chinese Medicine Syndrome Points;Therapeutic effect of Lown grading for ventricular premature beats;Heart rate variability;

Countries

the People's Republic of China

Contacts

Public ContactCui Haiming

Yueyang Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

seabright@126.com13918927624

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026